Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Contenuto fornito da Dr Neil Love. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Dr Neil Love o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)
Manage episode 441824714 series 1464173
Contenuto fornito da Dr Neil Love. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Dr Neil Love o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Featuring a slide presentation and related discussion from Dr Tiffany A Traina, including the following topics:
- Extended follow-up with pembrolizumab/chemotherapy for patients with previously untreated PD-L1-positive metastatic triple-negative breast cancer (mTNBC) (0:00)
- ASCENT trial: Survival advantage with sacituzumab govitecan versus physician’s choice of chemotherapy for patients with relapsed/refractory TNBC (2:49)
- Treatment-associated side effects with sacituzumab govitecan (5:32)
- Activity of sacituzumab govitecan irrespective of TROP2 expression level and in patients with brain metastases (6:48)
- Ongoing Phase III studies evaluating sacituzumab govitecan in earlier lines of treatment (eg, ASCENT-03, ASCENT-04) (8:51)
- Efficacy and tolerability of trastuzumab deruxtecan in patients with HER2-low and HER2-ultralow metastatic breast cancer (10:26)
- Activity and ongoing investigations of other novel agents and strategies for mTNBC (20:05)
1452 episodi
Manage episode 441824714 series 1464173
Contenuto fornito da Dr Neil Love. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Dr Neil Love o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Featuring a slide presentation and related discussion from Dr Tiffany A Traina, including the following topics:
- Extended follow-up with pembrolizumab/chemotherapy for patients with previously untreated PD-L1-positive metastatic triple-negative breast cancer (mTNBC) (0:00)
- ASCENT trial: Survival advantage with sacituzumab govitecan versus physician’s choice of chemotherapy for patients with relapsed/refractory TNBC (2:49)
- Treatment-associated side effects with sacituzumab govitecan (5:32)
- Activity of sacituzumab govitecan irrespective of TROP2 expression level and in patients with brain metastases (6:48)
- Ongoing Phase III studies evaluating sacituzumab govitecan in earlier lines of treatment (eg, ASCENT-03, ASCENT-04) (8:51)
- Efficacy and tolerability of trastuzumab deruxtecan in patients with HER2-low and HER2-ultralow metastatic breast cancer (10:26)
- Activity and ongoing investigations of other novel agents and strategies for mTNBC (20:05)
1452 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.